ConductScience.org, home

Paper39299010

Effects of xylazine on naloxone-precipitated fentanyl withdrawal in male and female rats.

Carlson HN and 2 others. Drug Alcohol Depend, 2024. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Effects of xylazine on naloxone-precipitated fentanyl withdrawal in male and female rats. Papers, record 39299010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39299010

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of xylazine on naloxone-precipitated fentanyl withdrawal in male and female rats.
PubMed
Journal
Drug Alcohol Depend
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
3.31, provisional
iCite
Revised in PubMed
2026-07-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Carlson HNHannah N
2Spera AGAnthony G
3Smith MAMark A

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Substance Withdrawal SyndromeMajor topic
NaloxoneMajor topic
FentanylMajor topic
XylazineMajor topic
Rats, Long-EvansMajor topic
Narcotic AntagonistsMajor topic
Animals
Male
Rats
Female
Analgesics, Opioid
Behavior, Animal

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 DA031725NIDA NIH HHSUnited StatesR01DA031725PubMed and NIHNIH RePORTER
R01 DA045364NIDA NIH HHSUnited StatesR01DA045364PubMed and NIHNIH RePORTER

Download CSV of grants

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137470999Xylazine suppresses fentanyl consumption during self-administration and induces a unique sex-specific withdrawal syndrome that is not altered by naloxone in rats.Exp Clin Psychopharmacol2024https://conductscience.org/library/papers/37470999PubMed
216289800Activation of the spinal ERK signaling pathway contributes naloxone-precipitated withdrawal in morphine-dependent rats.Pain2005https://conductscience.org/library/papers/16289800PubMed
321068718The role of TNFα in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats.Neuropsychopharmacology2011https://conductscience.org/library/papers/21068718PubMed
4391218963,3-Dibromoflavanone, a synthetic flavonoid derivative for pain management with antidepressant-like effects and fewer side effects than those of morphine in mice.Chem Biol Interact2024https://conductscience.org/library/papers/39121896PubMed
533316293Divergent profiles of fentanyl withdrawal and associated pain in mice and rats.Pharmacol Biochem Behav2021https://conductscience.org/library/papers/33316293PubMed
68848527Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score".Psychopharmacology (Berl)1995https://conductscience.org/library/papers/8848527PubMed
731042569Sex differences in the expression of morphine withdrawal symptoms and associated activity in the tail of the ventral tegmental area.Neurosci Lett2019https://conductscience.org/library/papers/31042569PubMed
838128606Impacts of xylazine on fentanyl demand, body weight, and acute withdrawal in rats: A comparison to lofexidine.Neuropharmacology2024https://conductscience.org/library/papers/38128606PubMed
935850178Modulation of morphine physical dependence and discriminative stimulus effects by ovarian hormones: Role of estradiol.Pharmacol Biochem Behav2022https://conductscience.org/library/papers/35850178PubMed
1037003572Advances in the characterization of negative affect caused by acute and protracted opioid withdrawal using animal models.Neuropharmacology2023https://conductscience.org/library/papers/37003572PubMed
1118308382Withdrawal from acute morphine dependence is accompanied by increased anxiety-like behavior in the elevated plus maze.Pharmacol Biochem Behav2008https://conductscience.org/library/papers/18308382PubMed
129678657Anxiogenic-like effects of spontaneous and naloxone-precipitated opiate withdrawal in the elevated plus-maze.Pharmacol Biochem Behav1998https://conductscience.org/library/papers/9678657PubMed
1330701615Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment.Am J Addict2019https://conductscience.org/library/papers/30701615PubMed
1423467277Noradrenergic synaptic function in the bed nucleus of the stria terminalis varies in animal models of anxiety and addiction.Neuropsychopharmacology2013https://conductscience.org/library/papers/23467277PubMed
15566320Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions.J Pharmacol Exp Ther1978https://conductscience.org/library/papers/566320PubMed
1637384558Illicitly Manufactured Fentanyl-Involved Overdose Deaths with Detected Xylazine - United States, January 2019-June 2022.MMWR Morb Mortal Wkly Rep2023https://conductscience.org/library/papers/37384558PubMed
1736704210Precipitated opioid withdrawal after buprenorphine administration in patients presenting to the emergency department: A case series.J Am Coll Emerg Physicians Open2023https://conductscience.org/library/papers/36704210PubMed
1817610870The CRF1 receptor antagonist, R121919, attenuates the severity of precipitated morphine withdrawal.Eur J Pharmacol2007https://conductscience.org/library/papers/17610870PubMed

Download CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
42600850Xylazine, veterinary anesthetic and recreational drug adulterant, reduces cephalic regeneration and alters defensive responding in planarians.Neurotoxicology2026https://conductscience.org/library/papers/42600850PubMed
42453353Discovery, Structural Characterization, and Preclinical Evaluation of Monoclonal Antibodies against Xylazine Poisoning.ACS Pharmacol Transl Sci2026https://conductscience.org/library/papers/42453353PubMed
42192162Adverse maternal and neonatal effects associated with perinatal xylazine exposure: a systematic review.J Perinatol2026https://conductscience.org/library/papers/42192162PubMed
41668254Xylazine Exposure and Association With Early Physiological and Withdrawal Symptoms in People With Opioid Use Disorder.J Addict Med2026https://conductscience.org/library/papers/41668254PubMed
41301461Within- and Between-Subject Analyses of the Effects of Chronic Xylazine on Negative Phototaxis in Two Planarian Species.Biomolecules2025https://conductscience.org/library/papers/41301461PubMed
41054596Naloxone reversal of the cardiorespiratory depressant effects of opioids and mixtures of opioids and stimulants in rats.Front Pharmacol2025https://conductscience.org/library/papers/41054596PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39299010

GET https://conductscience.org/api/papers/v1/39299010/authors